BeOne Medicines AG (BVMF:B1ME34)

BeOne Medicines AG Statistics

Total Valuation

BVMF:B1ME34 has a market cap or net worth of BRL 161.33 billion. The enterprise value is 143.07 billion.

Market Cap	161.33B
Enterprise Value	143.07B

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+7.75%
Shares Change (QoQ)	+0.75%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	68.38M

Valuation Ratios

The trailing PE ratio is 102.08 and the forward PE ratio is 47.54.

PE Ratio	102.08
Forward PE	47.54
PS Ratio	5.48
PB Ratio	6.72
P/TBV Ratio	6.81
P/FCF Ratio	31.10
P/OCF Ratio	25.98
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 45.51, with an EV/FCF ratio of 27.58.

EV / Earnings	90.52
EV / Sales	5.07
EV / EBITDA	45.51
EV / EBIT	62.64
EV / FCF	27.58

Financial Position

The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.25.

Current Ratio	3.41
Quick Ratio	2.97
Debt / Equity	0.25
Debt / EBITDA	1.79
Debt / FCF	1.16
Interest Coverage	7.68

Financial Efficiency

Return on equity (ROE) is 7.46% and return on invested capital (ROIC) is 30.49%.

Return on Equity (ROE)	7.46%
Return on Assets (ROA)	3.96%
Return on Invested Capital (ROIC)	30.49%
Return on Capital Employed (ROCE)	7.03%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.45M
Profits Per Employee	131,702
Employee Count	12,000
Asset Turnover	0.76
Inventory Turnover	1.21

Taxes

In the past 12 months, BVMF:B1ME34 has paid 715.60 million in taxes.

Income Tax	715.60M
Effective Tax Rate	31.17%

Stock Price Statistics

The stock price has increased by +7.52% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+7.52%
50-Day Moving Average	61.95
200-Day Moving Average	46.32
Relative Strength Index (RSI)	44.96
Average Volume (20 Days)	309

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.51

Income Statement

In the last 12 months, BVMF:B1ME34 had revenue of BRL 29.43 billion and earned 1.58 billion in profits. Earnings per share was 13.60.

Revenue	29.43B
Gross Profit	25.75B
Operating Income	2.46B
Pretax Income	2.30B
Net Income	1.58B
EBITDA	3.19B
EBIT	2.46B
Earnings Per Share (EPS)	13.60

Balance Sheet

The company has 25.05 billion in cash and 6.02 billion in debt, with a net cash position of 19.03 billion.

Cash & Cash Equivalents	25.05B
Total Debt	6.02B
Net Cash	19.03B
Net Cash Per Share	n/a
Equity (Book Value)	24.02B
Book Value Per Share	216.70
Working Capital	24.26B

Cash Flow

In the last 12 months, operating cash flow was 6.21 billion and capital expenditures -1.02 billion, giving a free cash flow of 5.19 billion.

Operating Cash Flow	6.21B
Capital Expenditures	-1.02B
Depreciation & Amortization	699.68M
Net Borrowing	20.20M
Free Cash Flow	5.19B
FCF Per Share	n/a

Margins

Gross margin is 87.49%, with operating and profit margins of 8.37% and 5.37%.

Gross Margin	87.49%
Operating Margin	8.37%
Pretax Margin	7.80%
Profit Margin	5.37%
EBITDA Margin	10.83%
EBIT Margin	8.37%
FCF Margin	17.63%

Dividends & Yields

BVMF:B1ME34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.75%
Shareholder Yield	-7.75%
Earnings Yield	0.98%
FCF Yield	3.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:B1ME34 has an Altman Z-Score of 4.83 and a Piotroski F-Score of 7.

Altman Z-Score	4.83
Piotroski F-Score	7